Thomas Kruijver

Director - Controller EU & Canada at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Thomas Kruijver's Colleagues at Alnylam Pharmaceuticals
Gertruud Haitsma

Sr Manager Market Access, Pricing & Policy CEMEA

Contact Gertruud Haitsma

Marielle Bouma

Associate Director Manufacturing

Contact Marielle Bouma

Kathy Mathijssen

International Payroll lead

Contact Kathy Mathijssen

Martin Durec

Accounting Manager Canada & EMEA

Contact Martin Durec

Michiel Openneer

Key Account Manager Netherlands

Contact Michiel Openneer

Raquel Quental

Manager Distribution & Commercial Quality Assurance

Contact Raquel Quental

View All Thomas Kruijver's Colleagues
Thomas Kruijver's Contact Details
HQ
(617) 551-8200
Location
Amsterdam, North Holland, Netherlands
Company
Alnylam Pharmaceuticals
Thomas Kruijver's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Thomas Kruijver
Thomas Kruijver currently works for Alnylam Pharmaceuticals.
Thomas Kruijver's role at Alnylam Pharmaceuticals is Director - Controller EU & Canada.
Thomas Kruijver's email address is ***@alnylam.com. To view Thomas Kruijver's full email address, please signup to ConnectPlex.
Thomas Kruijver works in the SaaS industry.
Thomas Kruijver's colleagues at Alnylam Pharmaceuticals are Gertruud Haitsma, Marielle Bouma, Kathy Mathijssen, Martin Durec, Michiel Openneer, Raquel Quental, Elena Veklenko and others.
Thomas Kruijver's phone number is (617) 551-8200
See more information about Thomas Kruijver